Dobutamine in severe Heart Failure More Questions than Answers

被引：0
作者：
Janssens, U. [1 ]
机构：
[1] St Antonius Hosp, Innere Med Klin, D-52249 Eschweiler, Germany
来源：
MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN | 2012年 / 107卷 / 01期
关键词：
NATIONAL REGISTRY ADHERE; LEVOSIMENDAN; DIAGNOSIS; TRIAL;
D O I：
10.1007/s00063-012-0077-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：63 / 65
页数：3
相关论文
共 50 条
  • [41] Comparison of the Effects of Levosimendan Dobutamine and Vasodilator Therapy on Ongoing Myocardial Injury in Acute Decompensated Heart Failure
    Gencer, Erkan
    Dogan, Volkan
    Ozturk, Mujgan Tek
    Nadir, Aydin
    Musmul, Ahmet
    Cavusoglu, Yuksel
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 22 (02) : 153 - 158
  • [42] BNP-guided therapy for chronic heart failure: anything more than just an attractive concept?
    Cowie, Martin R.
    EUROPEAN HEART JOURNAL, 2014, 35 (23) : 1507 - 1509
  • [43] The power of the right questions - iron therapy for heart failure
    von Haehling, Stephan
    Nitschmann, Sirka
    INNERE MEDIZIN, 2024, 65 (04): : 417 - 420
  • [44] Contrast induced nephropathy after coronary or vascular intervention: More biomarkers than answers
    Annamalai, Shiva K.
    Kapur, Navin K.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 91 (07) : 1192 - 1193
  • [45] Economic Evaluation of Levosimendan Versus Dobutamine for the Treatment of Acute Heart Failure in Italy
    Lucioni, Carlo
    D'Ambrosi, Alessandra
    Mazzi, Silvio
    Pollesello, Piero
    Apajasalo, Marjo
    Fedele, Francesco
    ADVANCES IN THERAPY, 2012, 29 (12) : 1037 - 1050
  • [46] Is Target Dose of Beta-Blocker More Important Than Achieved Heart Rate or Heart Rate Change in Patients with Systolic Chronic Heart Failure?
    Porapakkham, Pornwalee
    Porapakkham, Pramote
    Krum, Henry
    CARDIOVASCULAR THERAPEUTICS, 2010, 28 (02) : 93 - 100
  • [47] Amiodarone Attenuates the Proarrhythmic Effects of Dobutamine in Patients with Advanced Congestive Heart Failure
    Tsagalou, Eleftheria P.
    Gounopoulos, Pantelis
    Terrovitis, John V.
    Drakos, Stavros G.
    Katsaros, Fotios T.
    Kaldara, Elisabeth E.
    Alexopoulos, George P.
    Anastasiou-Nana, Maria I.
    HELLENIC JOURNAL OF CARDIOLOGY, 2009, 50 (03) : 193 - 198
  • [48] Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes
    Gevaert, Andreas B.
    Tibebu, Semra
    Mamas, Mamas A.
    Ravindra, Neal G.
    Lee, Shun Fu
    Ahmad, Tariq
    Ko, Dennis T.
    Januzzi, James L., Jr.
    Van Spall, Harriette G. C.
    ESC HEART FAILURE, 2021, 8 (04): : 2741 - 2754
  • [49] More than just a clinical syndrome: Biomarkers and echocardiography should be rapidly advised for anyone with suspected heart failure!
    Donal, Erwan
    Gegout, Louis
    Lee, K. Charlotte
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (03) : 561 - 563
  • [50] Economic Evaluation of Levosimendan Versus Dobutamine for the Treatment of Acute Heart Failure in Italy
    Carlo Lucioni
    Alessandra D’Ambrosi
    Silvio Mazzi
    Piero Pollesello
    Marjo Apajasalo
    Francesco Fedele
    Advances in Therapy, 2012, 29 : 1037 - 1050
12345